Why MakeMyTrip (MMYT) Is Up 5.8% After Analyst Caution on Earnings Ahead of July 22 Report and What's Next
- MakeMyTrip recently outperformed major market indices, drawing heightened attention ahead of its upcoming earnings report scheduled for July 22, 2025.
- Analyst forecasts have turned cautious, with downward earnings revisions and a low Zacks Rank signaling increased uncertainty about the company's near-term financial results.
- We’ll examine how this shift toward analyst caution and potential earnings volatility could affect MakeMyTrip’s investment narrative.
MakeMyTrip Investment Narrative Recap
To be a MakeMyTrip shareholder, you’d need to believe in India’s expanding travel industry and the company’s ability to harness that growth through new service offerings and improved digital experiences. The recent analyst caution before the July 22 earnings release signals increased uncertainty around short-term earnings momentum, and may heighten focus on near-term profit margins, the most important catalyst, while amplifying the risk of weaker-than-expected results, but these developments do not materially alter the long-term narrative for now.
Among recent announcements, the completed buyback transaction totaling US$3,000 million stands out, potentially influencing near-term earnings per share and capital allocation ahead of the upcoming results. This action, while not directly related to analyst downgrades, may provide some support to shareholder value as the company navigates a period of earnings volatility.
However, if supply challenges in the domestic air market linger, investors should be aware that...
Read the full narrative on MakeMyTrip (it's free!)
MakeMyTrip's narrative projects $1.7 billion revenue and $279.0 million earnings by 2028. This requires 20.9% yearly revenue growth and an earnings increase of $183.9 million from the current $95.1 million.
Uncover how MakeMyTrip's forecasts yield a $118.81 fair value, a 24% upside to its current price.
Exploring Other Perspectives
Simply Wall St Community members shared three fair value estimates for MakeMyTrip, ranging from US$32.56 to over US$180,922.76. As expectations for short-term earnings remain uncertain, see how your view stacks up against these diverse outlooks.
Build Your Own MakeMyTrip Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your MakeMyTrip research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
- Our free MakeMyTrip research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate MakeMyTrip's overall financial health at a glance.
Seeking Other Investments?
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
- Uncover 17 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.
- The end of cancer? These 25 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
- AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if MakeMyTrip might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com